Related Experiment Video
Updated: Nov 11, 2025

07:45
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Published on: May 18, 2020
6.5K
Laboratory Models for Investigating Breast Cancer Therapy Resistance and Metastasis.
Kevin Roarty1,2, Gloria V Echeverria1,2,3,4
1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States.
Frontiers in Oncology
|March 29, 2021
Summary
Developing effective breast cancer treatments requires robust laboratory models to study therapy resistance and metastasis. Understanding these complex processes is crucial for improving patient outcomes and developing new therapeutic strategies.
Area of Science:
- Oncology
- Cancer Biology
- Translational Research
Background:
- Breast cancer therapies are effective in early stages but often face challenges with resistance and metastasis.
- Therapy-resistant and metastatic breast cancers are treatable but currently incurable, necessitating advanced research models.
Purpose of the Study:
- To review existing and state-of-the-art laboratory models for studying breast cancer metastasis and therapy resistance.
- To discuss the limitations and advantages of various experimental approaches.
- To propose strategies for improving experimental modeling to advance breast cancer treatment development.
Main Methods:
- Review of historical and current laboratory model systems.
- Analysis of experimental approaches investigating breast cancer metastasis and therapy resistance.
- Discussion of model system limitations and advantages.
Main Results:
- Various model systems have provided critical insights into breast cancer metastasis and resistance.
- Many insights from these models have informed clinical trial regimens.
- Each model system possesses inherent limitations that require careful consideration.
Conclusions:
- Effective laboratory models are essential for understanding and overcoming breast cancer therapy resistance and metastasis.
- Improving experimental modeling is crucial for developing more effective breast cancer treatments.
- Continued research into advanced modeling systems will drive progress in clinical oncology.

